In the end, it wasn’t stakeouts or fingerprints or cell phone records that got him. It was a genealogy website.
How scientists can repurpose a bacterial immune system to alter DNA, making everything from cheap insulin to extra starchy corn.
Genetics pioneer Jennifer Doudna has launched the first commercial Crispr platform for detecting disease-causing DNA.
Get ready for more dramatic shifts between severe drought and record-breaking rainfall.
On a new health portal, 23andMe encourages customers to share how they manage common health conditions. It’s not hard to see who gets the better side of the deal.
With tons of amenities, the DNA sequencing giant hopes to attract the Bay Area's top life science talent.
With tons of amenities, the DNA sequencing giant hopes to attract the Bay Area's top life science talent.
"In 2017 we marched for science. In 2018, we vote for science."
Soon, anyone curious about their health will be able to request a clinical DNA test—not just doctors.
Poorly regulated stem cell treatments have blinded some macular degeneration patients. But a new technique is showing therapeutic promise.